MK

Murali Kannababu Guturu

Active Director Whole-Time Director DIN 00924669
DIN 00924669 First appointment Feb 1997 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 5 active board seats
Past companies 1 historical roles
Total affiliations 6 Since Feb 1997
Shareholding value •••• Premium profile

About Murali Kannababu Guturu

Data last updated:

Murali Kannababu Guturu is a Whole-Time Director at Esaote India (Ns) Limited (since 2015), Director at Guturu Private Limited (since 2020) and Director at Gemini Medical Networks Private Limited (since 2004), and holds 2 more current directorships. The companies operate in Healthcare, Infrastructure and Utilities and Real Estate and Construction. The 3 current companies with reported revenue have a combined latest revenue of ₹68.16 Cr; the largest is Esaote India (Ns) Limited at ₹45.70 Cr (FY 2024). Earlier, Murali Kannababu Guturu was a Director at Srikaram Infratech Private Limited (2011–2024).

DIN 00924669
Primary Designation Whole-Time Director
Industry Healthcare
First Appointment 11 Feb 1997
Oldest Company Age 29 yrs
Largest company Esaote India (Ns) Limited · ₹45.70 Cr (FY 2024)
Combined revenue ₹68.16 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Esaote India (Ns) Limited U32109GJ2000PLC038235
Whole-Time Director01 Oct 20152000₹45.70 Cr (FY 2024)Active
Guturu Private Limited U33208TG2020PTC139882
Director18 Mar 20202020₹14.46 Cr (FY 2025)Active
Director20 Sep 20042004₹8.01 Cr (FY 2025)Active
Director23 Sep 20112011Active
Director11 Feb 19971997Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Srikaram Infratech Private Limited U45400TN2011PTC082925
Director31 Oct 20112011₹67.7 Lakh (FY 2023)Active

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Murali Kannababu Guturu

Directorship timeline

Open interactive timeline →
Esaote India (Ns) Limited
Esaote Biomedica India Private Limited
Gemini Medical Networks Private Limited
Guturu Private Limited
Premium access

Shareholding and investment profile for Murali Kannababu Guturu

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Murali Kannababu Guturu

Murali Kannababu Guturu currently holds 5 directorships: Esaote India (Ns) Limited (Whole-Time Director, since 01 Oct 2015, revenue ₹45.70 Cr (FY 2024)); Guturu Private Limited (Director, since 18 Mar 2020, revenue ₹14.46 Cr (FY 2025)); Gemini Medical Networks Private Limited (Director, since 20 Sep 2004, revenue ₹8.01 Cr (FY 2025)); Guturu Infrastructure Private Limited (Director, since 23 Sep 2011); Esaote Biomedica India Private Limited (Director, since 11 Feb 1997).

Murali Kannababu Guturu was first appointed on 11 Feb 1997 as Director at Esaote Biomedica India Private Limited. The most recent appointment on record is 18 Mar 2020 at Guturu Private Limited.

The 3 current companies of Murali Kannababu Guturu that report revenue have a combined latest revenue of ₹68.16 Cr: Esaote India (Ns) Limited ₹45.70 Cr (FY 2024); Guturu Private Limited ₹14.46 Cr (FY 2025); Gemini Medical Networks Private Limited ₹8.01 Cr (FY 2025).

Murali Kannababu Guturu held 1 earlier board appointment: Srikaram Infratech Private Limited (Director, 31 Oct 2011 to 10 Jul 2024).

The current boards of Murali Kannababu Guturu's companies include Mohanlal Vasudevannairap Kizhepat (Esaote India (Ns) Limited), Sukumar Venkutusamy (Esaote India (Ns) Limited), Vidyullatha Guturu (Esaote India (Ns) Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available